Metallomics-based platforms for comparing the human blood serum profiles between bipolar disorder and schizophrenia patients.

Gustavo de Souza PessôaJemmyson Romário de JesusTiago Santana BalbuenaMarco Aurélio Zezzi Arruda

Published in: Rapid communications in mass spectrometry : RCM (2020)

This approach brings new perspectives to the comprehension of mood disorders, highlighting the importance of metallomics science in disease development. This strategy showed an innovative potential for evaluating mood disorders at the proteomic level, making it possible to identify proteins related to mood disorders and BD.

Keyphrases

bipolar disorder
major depressive disorder
end stage renal disease
ejection fraction
endothelial cells
chronic kidney disease
newly diagnosed
peritoneal dialysis
public health
prognostic factors
patient reported outcomes
climate change
patient reported